Y-J. Bang - Concepedia

Author

Y-J. Bang

Seoul National University Hospital

Also Known As

Y-J Bang, Y-J. Bang, Y. Bang, Y.-J. Bang, Y.J. BANG, Y.J. Bang, YJ Bang, Yujin Bang

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Seoul National University Hospital Seoul National University National Cancer Center Hospital East Seoul National University Bundang Hospital Samsung Medical Center

About

Y-J. Bang is an author at Seoul National University Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	525
2	Gastroenterology	6	6	147
3	Immunology	3	3	133
4	Health Sciences	2	2	132
5	Cell Biology	1	1	108

Y-J. Bang

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study Xin Su, Ping Zhan, Paul R. Gavine, British Journal of Cancer	2014	183
MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome Heeji Lee, Min‐Sun Kim, Hye Seung Lee, British Journal of Cancer	2012	178
Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer Seung Woo Han, D-Y. Oh, S-A Im, British Journal of Cancer	2009	138
Involvement of NF- B and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein Sang–Hyoun Kim, Jung‐Min Oh, Jae Hong No, Carcinogenesis	2009	109
Testican-1-mediated epithelial–mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer Hyoung‐Pyo Kim, S-W Han, SH Song, Oncogene Tumor BiologyOncologyGastrointestinal OncologyMedicineTestican-1-mediated Epithelial–mesenchymal Transition	2013	108
High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer Dae‐Wi Kim, Hanbo Min, Kelvin H. Lee, British Journal of Cancer	2008	98
Antibiotic use during the last days of life in cancer patients Dong Yoon Oh, J. Kim, Dong‐Wan Kim, European Journal of Cancer Care Terminal Stage CancerPathologyAntimicrobial ChemotherapyCancer PatientsTerminal Cancer Patients	2006	82
Biomarker analysis in stage III–IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival J-S Kim, M-A Kim, T. M. Kim, British Journal of Cancer	2009	55
Metaplastic Breast Carcinoma: Clinicopathologic Features and Prognostic Value of Triple Negativity Kyu‐Hyoung Lim, Dong Yoon Oh, Eui Kyu Chie, Japanese Journal of Clinical Oncology	2009	54
CA-170, a first in class oral small molecule dual inhibitor of immune checkpoints PD-L1 and VISTA, demonstrates tumor growth inhibition in pre-clinical models and promotes T cell activation in Phase 1 study John D. Powderly, Manish R. Patel, Jina Lee, Annals of Oncology Cancer ImmunosurveillanceMedicineImmunologyTumor Growth InhibitionImmune Checkpoint Inhibitor	2017	54

Page 1